Respiratory Infections News

Novavax on Monday announced that it has submitted an emergency use authorization request to the FDA for its protein-based COVID-19 vaccine for individuals aged 18 years or older.

The FDA on Monday approved Moderna’s COVID-19 vaccine, making it the second fully approved COVID-19 vaccine in the United States.

People previously infected with SARS-CoV-2 are substantially protected against COVID-19 for several months, even in the absence of vaccination, a study found.

The AAP urged that school districts prioritize in-person learning in updates to their interim pandemic guidance published today.

Researchers identified four factors that may anticipate if a patient will develop long COVID.

Adolescents who were homeschooled during a COVID-19 lockdown slept longer on school days and drank less alcohol and caffeine than before the pandemic, according to a cross-sectional online survey of nearly 9,000 students in Switzerland.

Moderna on Wednesday announced the start of a phase 2 study of an omicron-specific COVID-19 booster shot.

The New England Journal of Medicine on Wednesday published data from the ongoing NIH-sponsored trial that led the FDA last fall to authorize the mix-and-match strategy for COVID-19 vaccine boosters.

Omicron has taxed the country’s health care system, causing more COVID-19 cases, ED visits and hospitalizations than any other variant during the pandemic, according to newly published data.

Pfizer and BioNTech said Tuesday that they have initiated a clinical study to assesses the safety and efficacy of a COVID-19 vaccine for adults aged 18 to 55 years that specifically targets the omicron variant of SARS-CoV-2.